Embla Medical hf. (CPH:EMBLA)

Embla Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	102.07	86.16	72.65	76.63	85.2	102.36
Cash & Short-Term Investments	102.07	86.16	72.65	76.63	85.2	102.36
Cash Growth	25.70%	18.59%	-5.19%	-10.05%	-16.77%	74.65%
Accounts Receivable	146.67	121.92	127.84	112.37	102.77	98.35
Other Receivables	-	7.36	5.52	4.36	2.76	13.64
Receivables	146.67	129.28	133.37	116.74	105.52	112
Inventory	167.23	143.1	136.23	132.13	103.99	93.23
Prepaid Expenses	-	22.63	17.66	14.5	14.05	12.84
Other Current Assets	49.38	15.78	16.07	8.86	9.48	6.02
Total Current Assets	465.35	396.96	375.98	348.85	318.23	326.46
Property, Plant & Equipment	236.03	199.63	186.06	179.32	182.08	171.38
Long-Term Investments	27.06	21.22	23.44	17.08	13.65	13.35
Goodwill	836.6	776.31	690.86	680.4	644.15	612.19
Other Intangible Assets	100.15	96.65	65.84	62	58.84	59.5
Long-Term Deferred Tax Assets	52.43	46.37	41.89	37.32	27.04	27.51
Other Long-Term Assets	4.18	1.85	1.63	0.39	2.92	3.94
Total Assets	1,722	1,539	1,386	1,325	1,247	1,214
Accounts Payable	32.86	27.28	30.75	28.65	26.72	20.02
Accrued Expenses	52.72	76.73	78.86	63.35	62.49	60.68
Current Portion of Long-Term Debt	23.46	28.62	21.53	62.07	46.04	17.55
Current Portion of Leases	27.73	24.14	21.79	24.77	21.24	17.86
Current Income Taxes Payable	23.03	18.31	12.14	11.01	7.35	4.16
Current Unearned Revenue	-	2.72	2.84	3.32	3.37	3.1
Other Current Liabilities	93.17	31.5	28.28	43.84	19.24	23.94
Total Current Liabilities	252.95	209.28	196.2	237.01	186.46	147.31
Long-Term Debt	361.54	328.75	311.8	277.71	262.19	339.98
Long-Term Leases	149.71	118.28	112.61	116.38	118.67	108.01
Long-Term Unearned Revenue	10.82	8.59	7.28	6.04	6.25	6.74
Long-Term Deferred Tax Liabilities	36.52	37.48	28.78	29.6	29.03	26.05
Other Long-Term Liabilities	40.29	55.88	24.02	23.12	17.72	9.05
Total Liabilities	851.83	758.27	680.68	689.85	620.32	637.14
Common Stock	4.84	4.83	4.78	4.78	4.8	4.79
Additional Paid-In Capital	96.25	88.64	61.48	61.43	70.78	70.08
Retained Earnings	818.18	760.38	700.93	641.23	593.2	530.42
Comprehensive Income & Other	-51.53	-76.66	-65.31	-71.74	-47.18	-32.78
Total Common Equity	867.74	777.19	701.88	635.7	621.59	572.51
Minority Interest	2.24	3.51	3.12	-0.19	5.01	4.68
Shareholders' Equity	869.97	780.7	705.01	635.51	626.6	577.19
Total Liabilities & Equity	1,722	1,539	1,386	1,325	1,247	1,214
Total Debt	562.44	499.79	467.73	480.92	448.15	483.39
Net Cash (Debt)	-460.36	-413.63	-395.08	-404.29	-362.95	-381.03
Net Cash Per Share	-1.07	-0.97	-0.94	-0.97	-0.86	-0.90
Filing Date Shares Outstanding	427.85	426.93	420.3	420.29	422.26	422.1
Total Common Shares Outstanding	427.85	426.93	420.3	420.29	422.26	422.1
Working Capital	212.4	187.67	179.78	111.84	131.78	179.15
Book Value Per Share	2.03	1.82	1.67	1.51	1.47	1.36
Tangible Book Value	-69.02	-95.77	-54.81	-106.7	-81.4	-99.18
Tangible Book Value Per Share	-0.16	-0.22	-0.13	-0.25	-0.19	-0.23
Buildings	-	-	-	2.26	1.61	2.25
Machinery	124.2	109	101.68	129.71	135.77	130.55
Leasehold Improvements	60.61	51.27	42.81	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.